Caroline Litchfield

Director of Finance/CFO bei IMMUNE DESIGN CORP

Vermögen: - $ am 31.03.2024

55 Jahre

Health Technology

Consumer Services

Aktive Positionen von Caroline Litchfield

Unternehmen	Position	Beginn	Ende
IMMUNE DESIGN CORP	Director/Board Member	02.04.2019	-
	Director of Finance/CFO	-	-
	Treasurer	02.04.2019	-
MERCK & CO., INC.	Director of Finance/CFO	01.04.2021	-
MERCK & CO., INC.	Treasurer	01.01.2018	01.04.2021

Unternehmen	Position	Beginn	Ende
ORGANON & CO.	Director/Board Member	-	31.05.2021
FULFORD (INDIA) LIMITED	Director/Board Member	04.08.2013	30.01.2014
Organon Pharma (UK) Ltd. Organon Pharma (UK) Ltd. Pharmaceuticals: MajorHealth Technology Organon Pharma (UK) Ltd. develops and manufactures pharmaceuticals. It offers osteoarthritis pain treatment Arcoxia, cardiovascular medication Cozaar, HIV drug Crixivan and asthma treatment Singulair. It operates a research center specializing in the development of central nervous system disorder such as Alzheimer's disease, depression, anxiety and migrane. The company was founded in 1953 and is headquartered in Hoddesdon, the United Kingdom.	Director of Finance/CFO	-	23.06.2009

University of Leicester

Undergraduate Degree

International

Operativ

Sektoral

Health Technology	6
Consumer Services	2

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	2
MERCK & CO., INC.	Health Technology
ORGANON & CO.	Health Technology

Private Unternehmen	3
Fulford (India) Ltd. Fulford (India) Ltd. Pharmaceuticals: MajorHealth Technology Fulford (India) Ltd. engages in the wholesale of pharmaceutical and medical goods. Its products include speciality health care and fertility, oncology, quadriderm, elocon, elosalic, dipsalic, and emolene. The company was founded on March 2, 1948 and is headquartered in Mumbai, India.	Health Technology
Organon Pharma (UK) Ltd. Organon Pharma (UK) Ltd. Pharmaceuticals: MajorHealth Technology Organon Pharma (UK) Ltd. develops and manufactures pharmaceuticals. It offers osteoarthritis pain treatment Arcoxia, cardiovascular medication Cozaar, HIV drug Crixivan and asthma treatment Singulair. It operates a research center specializing in the development of central nervous system disorder such as Alzheimer's disease, depression, anxiety and migrane. The company was founded in 1953 and is headquartered in Hoddesdon, the United Kingdom.	Health Technology
Immune Design Corp. Immune Design Corp. Pharmaceuticals: MajorHealth Technology Immune Design Corp. is a clinical-stage immunotherapy company focused on cancer with in vivo approaches designed to enable the body's immune system to fight disease. It develops multiple product candidates from its discovery platforms, ZVex and GLAAS. The company was founded by Steven G. Reed and David Baltimore on February 20, 2008 and is headquartered in Kenilworth, NJ.	Health Technology